United States v. Parke, Davis & Co. Notable Ruling Explained

The United States v. Parke, Davis & Co. case is a significant landmark in American pharmaceutical law. The company was charged with violating the 1912 Pure Food and Drug Act.

Parke, Davis & Co. was accused of misbranding their product, Strychnine, by failing to include adequate instructions for use. This was a major concern, as Strychnine is a highly toxic substance.

The court ultimately ruled in favor of the government, finding Parke, Davis & Co. guilty of violating the Pure Food and Drug Act.

Readers also liked: Meyer Brothers Drug Company

The government accused Parke, Davis & Company of violating the Sherman Act by conspiring to maintain resale prices of its pharmaceutical products. The case, United States v. Parke, Davis & Co., was a significant one, and here are the key facts.

The petitioner in the case was the United States, which brought the lawsuit against Parke, Davis & Company. The respondent type was a drug manufacturer, and the citation for the case is 362 U.S. 29.

The court took jurisdiction through an appeal, and the type of decision made was an opinion of the court that was orally argued. The chief justice at the time was Earl Warren, and the majority opinion was written by Justice William Brennan.

For another approach, see: Debt Justice

The Supreme Court ultimately decided the case of United States v. Parke, Davis & Co. in favor of the government.

The Court held that Parke Davis' actions went beyond mere customer selection and created combinations or conspiracies to enforce resale price maintenance in violation of the Sherman Act.

The district court's dismissal of the case was deemed an abuse of discretion, as Parke Davis had stopped its scheme due to an investigation by the Department of Justice.

The majority opinion in the Court Ruling was delivered by Justice Brennan. He began by reviewing the 1919 decision in United States v. Colgate & Co., which set the stage for the issue at hand.

The Government conceded that a manufacturer can use the Colgate doctrine to enforce a price-maintenance policy by refusing to deal with customers who don't comply. However, they argued that Parke Davis' actions went beyond mere customer selection and created combinations or conspiracies to enforce resale price maintenance in violation of the Sherman Act.

Explore further: Railroad Track Maintenance Tax Credit

Justice Brennan focused on the fact that the district court dismissed the case, but only because Parke Davis had discontinued their scheme. This dismissal was seen as an abuse of discretion.

The Court noted that Parke Davis stopped their efforts because the Department of Justice had instituted an investigation. This is a crucial point, as it highlights the impact of government action on business decisions.

Here's a summary of the key points in the majority opinion:

The dissenting opinion in this court ruling is a strong one. Justice Harlan is not happy with the majority's decision.

The Court's opinion has sent the Colgate doctrine to its demise, which has been a part of antitrust law since 1919. This doctrine was a basic concept that guided business practices.

Justice Harlan finds the majority's new standard vague and incomprehensible. He's left wondering what the new standard is for determining a "contract, combination... or conspiracy" under the Sherman Act.

The majority's treatment of the trial court's findings is seen as a disguised overruling of the Colgate doctrine. This is a significant change in the law.

Justice Harlan denies that Parke Davis went beyond the limits set by the Colgate doctrine. He thinks the majority's decision is a hollow victory that doesn't truly respect the Colgate doctrine.